查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1928641

翻新C型臂市场按产品类型、检测类型、技术、应用和最终用户划分，全球预测（2026-2032）

Refurbished C-Arms Market by Product Type, Detector Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，翻新 C 型臂市场价值将达到 2.4533 亿美元，到 2026 年将成长至 2.6728 亿美元，到 2032 年将达到 4.1275 亿美元，复合年增长率为 7.71%。

关键市场统计数据
基准年 2025 2.4533亿美元
预计年份：2026年 2.6728亿美元
预测年份 2032 4.1275亿美元
复合年增长率 (%) 7.71%

将翻新的C型臂作为临床有效且资本效率高的诊断影像设备进行策略性应用，正在重塑采购流程和临床工作流程。

在现代医疗环境中，翻新的C型臂系统正日益被视为平衡临床需求和资金管理的有效解决方案。这些系统可在广泛的临床领域提供诊断和治疗影像功能，并且在预算限制、快速部署需求和资源最佳化至关重要的情况下，经常被用作新设备的理想替代方案。因此，医院、门诊手术中心、诊所和诊断中心正在重新思考其诊断影像设备的采购路径和生命週期管理。

本文简要概述了正在推动翻新C臂生态系统专业化并转变需求驱动因素的变革性技术、临床和采购变化。

受技术成熟、临床实践变化和采购理念演变的驱动，翻新C型臂的市场环境正在经历一场变革。随着数位影像工作流程的整合、检测器效能的提升以及服务通讯协定的改进，翻新产品与新产品之间的功能差距正在缩小。因此，临床团队和采购负责人越来越多地评估翻新产品，尤其是经过检验测试、零件更换和软体校准的产品，以用于各种常规和复杂的手术。

分析关税制度变化对翻新C臂筹资策略、供应链韧性及总成本估算的影响

关税政策和进口法规正直接影响翻新医疗设备的经济效益，并重塑依赖跨国翻新供应链的医疗服务提供者的采购策略。关税制度的变化可能会影响翻新系统和备件的到岸成本，改变供应商的路线选择，并促使区域翻新中心和本地伙伴关係关係的建立，从而降低进口关税风险。因此，医疗采购商和服务供应商正在透过供应商网路多元化和评估替代采购模式（包括与当地翻新合作伙伴和签订当地服务合约）来适应变化。

关键的细分洞察，将产品类型、临床应用、用户环境、检测器选择和技术平台与采购和营运优先顺序相匹配。

细分市场提供了一个系统性的观点，帮助我们了解翻新C型臂在哪些方面能发挥最大的营运和临床价值。根据产品类型，医疗机构将固定式系统（提供稳定、高通量的成像室）与移动式设备（优先考虑便携性和灵活的房间布置）区分开来。这种区分会影响采购决策，因为医疗机构需要在处理容量要求和手术种类之间取得平衡。根据应用领域，翻新C型臂被广泛应用于各个专科，包括循环系统、消化病学、普通外科、神经病学、整形外科、疼痛管理和泌尿系统。循环系统可进一步细分为诊断性和介入性心臟病学，而一般外科则可区分微创手术和开放性手术。这些临床差异决定了影像品质要求、检测器偏好和服务水准预期。

从全面的区域观点出发，深入分析美洲、欧洲、中东和非洲以及亚太地区的趋势如何推动需求、服务和筹资策略的差异化。

区域趋势深刻影响着翻新C臂机的应用模式、服务生态系和供应商策略。在美洲，成熟的医疗网络和完善的次市场孕育了强大的分销管道和完善的服务基础设施，从而实现了快速部署和可预测的维护週期。随着医疗服务从都市区三级医疗中心向乡村医疗机构转移，该地区的买家需要在成本控制与手术范围和影像品质之间寻求平衡。

竞争性评估清楚地表明，技术严谨性、服务品质和策略​​合作伙伴关係如何使翻新C臂供应商脱颖而出，并推动医疗机构采用这些设备。

翻新C型臂市场的竞争格局由专业翻新商、认证服务供应商、独立再製造商和临床设备经销商组成。领先企业凭藉严谨的技术、透明的检验流程和完善的售后支援脱颖而出。那些投资于标准化测试通讯协定、可追溯的零件更换和认证服务技术人员的公司，已在医院和诊断中心获得了较高的机构认可度和回头客。

针对医疗领导者，就翻新C型臂引入检验标准化、供应链多元化以及加强与临床工程部门的合作等方面，提出切实有效的建议。

产业领导者应采取多管齐下的策略，整合技术检验、供应链韧性和相关人员协作，以充分利用翻新C型臂的市场机会。首先，医疗负责人应制定正式的验收标准和标准化测试通讯协定，在部署前检验影像品质、机械完整性和软体性能。将这些标准纳入采购合约可以减少歧义，并协调临床团队和供应商之间的预期。

采用透明的混合方法调查方法，结合关键相关人员对话、技术检验审查和资料三角测量，以获得可操作的见解。

本分析整合了混合方法研究的成果，该方法结合了对技术文献、监管指南和检验的翻新标准的系统性回顾，以及与临床工程师、采购负责人、翻新专家和诊断影像医师的直接访谈。二手资料提供了技术趋势、检测器性能特征和法规结构的背景信息，而直接访谈则提供了关于采购週期、安装挑战和服务预期等方面的运营观点。

综合研究结果表明，当管治、标准和供应弹性协调一致时，翻新的 C 型臂可以作为具有战略意义且永续的诊断成像资产。

翻新C型臂是临床能力与资本管理相结合的实用方案，具有大幅扩展不同医疗机构介入和诊断影像检查覆盖范围的潜力。翻新标准的提升、临床认可的提高以及灵活的采购模式，使翻新系统成为现代成像策略中不可或缺的组成部分。然而，要充分发挥这一潜力，需要严格的检验通讯协定、稳健的供应链以及临床和工程相关人员的紧密合作，以确保性能稳定并符合监管要求。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的翻新C型臂市场

  • 固定的
  • 移动的

9. 按检测器类型分類的翻新C型臂市场

  • 平板检测器
  • 影像增强器

第十章 按技术分類的翻新C臂市场

  • 模拟
  • 数位的

第十一章 按应用分類的翻新C型臂市场

  • 心臟病学
    • 诊断心臟病学
    • 介入性心臟病学
  • 胃肠病学
  • 一般外科
    • 微创手术
    • 开放性手术
  • 神经病学
  • 整形外科
  • 疼痛管理
  • 泌尿系统

第十二章 翻新C臂市场（依最终用户划分）

  • 门诊手术中心
  • 诊所
  • 诊断中心
  • 医院
    • 公立医院
    • 私立医院

第十三章 各地区翻新C臂市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 翻新C臂市场（依团体划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国翻新C型臂市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国翻新C型臂市场

第十七章 中国翻新C臂市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agito Medical A/S
  • Avante Health Solutions, Inc.
  • Block Imaging, Inc.
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • EverX Pty Ltd
  • Fair Medical Co., Ltd.
  • Fujifilm Healthcare
  • Future Health Concepts, Inc.
  • GE Healthcare, Inc.
  • Hilditch Group Ltd.
  • Hitachi Medical Systems
  • Integrity Medical Systems, Inc.
  • Koninklijke Philips NV
  • Master Medical Equipment, LLC
  • Nationwide Imaging Services, Inc.
  • Pacific Healthcare Imaging, LLC
  • Radiology Oncology Systems, Inc.（ROS）
  • Radon Medical Imaging LLC
  • Siemens Healthineers AG
  • Soma Technology, Inc.
  • Ultra Imaging Solutions, LLC
  • US Med-Equip, Inc.
  • Venture Medical ReQuip, Inc.
  • Whittemore Enterprises, Inc.
Product Code: MRR-92740D85F086

The Refurbished C-Arms Market was valued at USD 245.33 million in 2025 and is projected to grow to USD 267.28 million in 2026, with a CAGR of 7.71%, reaching USD 412.75 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 245.33 million
Estimated Year [2026] USD 267.28 million
Forecast Year [2032] USD 412.75 million
CAGR (%) 7.71%

A strategic introduction that frames refurbished C-arms as clinically effective, capital-efficient imaging assets reshaping procurement and clinical workflows

Refurbished C-arm systems are increasingly recognized as pragmatic solutions that reconcile clinical imperatives with capital stewardship in contemporary healthcare environments. These systems offer diagnostic and interventional imaging capabilities that extend across a wide array of procedural disciplines, and they frequently serve as pragmatic alternatives to new equipment where budgetary constraints, rapid deployment needs, or resource optimization are paramount. As a result, hospitals, ambulatory surgical centers, clinics, and diagnostic centers are reassessing procurement pathways and lifecycle management for imaging assets.

In this context, refurbished C-arms present a confluence of clinical utility, technological compatibility, and procurement flexibility. They enable institutions to maintain procedural throughput and imaging quality while deferring or reducing capital expenditure. Moreover, refurbishment strategies often include preventative maintenance agreements, parts replacement, and software updates that extend operational lifespan and facilitate interoperability with other imaging and record systems. This introductory framing underscores the practical value proposition of refurbished C-arms and sets the stage for a deeper exploration of market dynamics, regulatory influences, and operational considerations that influence adoption across diverse clinical settings.

Consequently, decision-makers should view refurbished C-arms not merely as cost-reduction instruments but as strategic enablers of care continuity and capital efficiency. The remainder of this executive summary elaborates on transformative shifts, tariff implications, segmentation insights, regional differentials, competitive dynamics, and clear recommendations for leaders pursuing sustainable imaging strategies.

A concise synthesis of transformative technological, clinical, and procurement shifts that are professionalizing the refurbished C-arm ecosystem and altering demand drivers

The landscape for refurbished C-arms is undergoing transformative shifts driven by technological maturation, changing clinical practices, and evolving procurement philosophies. Increasingly, integration of digital imaging workflows, enhanced detector performance, and improved servicing protocols have narrowed the functional gap between refurbished and new systems. As a result, clinical teams and procurement leaders are more willing to evaluate refurbished equipment for routine and complex procedures, particularly when refurbishment includes validated testing, component replacement, and software calibration.

At the same time, clinical workload patterns and the decentralization of care are reshaping demand. Ambulatory surgical centers and outpatient interventional suites are expanding procedural scope, creating new avenues for refurbished equipment deployment. In parallel, hospitals are prioritizing asset flexibility and rapid redeployment across departments to manage episodic surges in demand. These shifts favor refurbishers that can deliver rapid turnkey installations, validated reconditioning, and service agreements that mirror the reliability expectations of larger institutions.

Additionally, regulatory scrutiny and quality assurance expectations have risen, prompting vendors and refurbishers to adopt standardized validation protocols and traceable service histories. This convergence of technical, clinical, and regulatory factors is catalyzing a professionalization of the refurbishment ecosystem and creating differentiated value propositions for suppliers that combine technical rigor with cost-conscious delivery models.

An analysis of how evolving tariff regimes are reshaping procurement strategies, supply chain resilience, and total cost considerations for refurbished C-arm acquisition

Tariff policies and import regulations exert an immediate influence on the economics of refurbished imaging equipment, reshaping procurement calculus for healthcare providers that rely on cross-border refurbishment supply chains. Changes in tariff regimes can affect the landed cost of refurbished systems and spare parts, alter vendor routing decisions, and incentivize regional refurbishment hubs or local partnerships that reduce exposure to import duties. Healthcare buyers and service providers are therefore adapting by diversifying supplier networks and evaluating alternative sourcing models, including domestic refurbishment partners and in-country service agreements.

In response to tariff-driven cost variability, procurement teams are prioritizing contractual flexibility and supply chain resilience. This includes negotiating fixed-price service contracts, exploring consignment models for critical spare parts, and establishing multi-vendor frameworks to mitigate single-source dependencies. These tactical adjustments help institutions stabilize operational budgets and preserve procedural capacity despite potential cost shifts tied to tariff actions.

Moreover, tariffs catalyze broader strategic considerations, such as evaluating the total cost of ownership beyond initial purchase price. Organizations are increasingly weighing service quality, warranty terms, availability of trained biomedical staff, and the logistical complexity of redeployment when making procurement decisions. As a result, tariff changes do not simply affect price-they influence competitive positioning, vendor selection criteria, and the development of localized service capabilities that support long-term sustainability.

Key segmentation insights that align product types, clinical applications, user settings, detector choices, and technology platforms with procurement and operational priorities

Segmentation offers a structured lens for understanding where refurbished C-arms deliver the most operational and clinical value. Based on product type, institutions differentiate between fixed systems that provide stable, high-throughput imaging suites and mobile units that prioritize portability and flexible room deployment. This distinction influences procurement decisions as facilities balance throughput needs against space constraints and procedural diversity. Based on application, refurbished C-arms serve a wide span of specialties including cardiology, gastroenterology, general surgery, neurology, orthopedics, pain management, and urology, with cardiology further dividing into diagnostic and interventional use cases while general surgery differentiates between minimally invasive and open procedures; these clinical nuances dictate image quality requirements, detector preferences, and service-level expectations.

Based on end user, deployment contexts range from ambulatory surgical centers and clinics to diagnostic centers and hospitals, with hospitals further categorized into government and private facilities that exhibit distinct procurement cycles and budgetary frameworks. The ownership and governance model of the end user often informs warranty tolerance, expected uptime, and acceptance testing protocols. Based on detector type, choices between flat panel detectors and image intensifiers affect image resolution, dose management, and procedural suitability, while technology classification into analog and digital systems shapes integration complexity with modern PACS and reporting workflows. By interpreting these segmentation dimensions together, leaders can match refurbished configurations to clinical needs, operational constraints, and long-term service strategies to maximize both clinical outcomes and asset utilization.

A comprehensive regional perspective detailing how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics drive differentiated demand, servicing, and procurement tactics

Regional dynamics profoundly influence adoption patterns, service ecosystems, and vendor strategies for refurbished C-arms. In the Americas, established healthcare networks and mature secondary markets favor robust redistributor channels and comprehensive service infrastructures, enabling rapid deployment and predictable maintenance cycles. Transitioning from urban tertiary centers to rural facilities, buyers in this region balance cost management with expectations for procedural range and imaging quality.

Across Europe, Middle East & Africa, regulatory heterogeneity and variable healthcare funding models create differentiated adoption profiles. Western European facilities tend to emphasize compliance and standardized refurbishment documentation, while markets in the Middle East and Africa often prioritize rapid availability and adaptable financing solutions. As a result, successful suppliers tailor certification and service packages to meet diverse regulatory and operational requirements across subregions.

In Asia-Pacific, rapid investment in outpatient procedural capacity and a broad spectrum of healthcare facility types-from advanced metropolitan hospitals to resource-constrained regional clinics-drives demand for both high-end and cost-efficient refurbished systems. Networked procurement strategies and regional refurbishment hubs emerge as effective mechanisms to support fast turnaround, parts availability, and localized technical support. Collectively, these regional characteristics shape how refurbishers allocate inventory, design service offerings, and partner with clinical stakeholders to ensure reliable performance across varied geographies.

An incisive competitive assessment highlighting how technical rigor, service excellence, and strategic partnerships differentiate refurbished C-arm providers and drive institutional adoption

Competitive dynamics in the refurbished C-arm space reflect a blend of specialized refurbishers, authorized service providers, independent remanufacturers, and clinical equipment distributors. Leading players differentiate on technical rigor, transparent validation processes, and the breadth of aftermarket support. Those that invest in standardized testing protocols, traceable component replacement, and certified service technicians achieve higher institutional acceptance and repeat business among hospitals and diagnostic centers.

Moreover, strategic partnerships between refurbishers and hospital biomedical engineering teams are becoming increasingly important. These collaborations expedite acceptance testing, streamline installations, and align preventive maintenance schedules with clinical workflows. Vendors that provide robust service-level agreements, remote diagnostic capabilities, and modular upgrade paths can convert initial transactions into long-term service relationships. In addition, companies that offer tailored financing solutions and short-term leasing options enable customers to trial refurbished systems with reduced capital exposure.

Finally, differentiators such as rapid parts availability, documented compliance, and demonstrable uptime metrics influence procurement committees that evaluate risk and clinical continuity. As clinical teams demand consistent imaging performance, firms that can combine reliability with cost-effectiveness will sustain competitive advantage and expand their footprint across multiple end-user segments.

Practical, high-impact recommendations for healthcare leaders to standardize validation, diversify supply chains, and strengthen clinical-engineering collaboration for refurbished C-arm adoption

Industry leaders should adopt a multi-pronged strategy that integrates technical validation, supply chain resilience, and stakeholder alignment to capitalize on refurbished C-arm opportunities. First, institutional buyers must formalize acceptance criteria and standardized testing protocols that validate image quality, mechanical integrity, and software performance prior to commissioning. Embedding these criteria in procurement contracts reduces ambiguity and aligns expectations between clinical teams and suppliers.

Second, organizations should diversify sourcing channels and cultivate local service partnerships to mitigate geopolitical and tariff-related risks. Establishing regional refurbishment hubs or authorized service agreements ensures faster turnaround for parts and repairs, and enhances continuity of care. Third, clinical and biomedical engineering teams should collaborate early in the procurement cycle to define performance tolerances and integration requirements with PACS and electronic health systems. This cross-functional coordination reduces installation friction and shortens time-to-first-use.

Finally, procurement leaders should require transparent documentation of refurbishment processes, component provenance, and warranty terms as part of vendor evaluation. These contractual safeguards and performance metrics enable clearer accountability and support long-term lifecycle planning. By implementing these measures, stakeholders can harness the clinical and operational advantages of refurbished C-arms while managing risk and preserving quality of care.

A transparent, mixed-methods research methodology combining primary stakeholder engagement, technical validation review, and data triangulation to produce actionable findings

This analysis synthesizes insights derived from a mixed-methods research approach that combines systematic review of technical literature, regulatory guidance, and validated refurbishment standards with primary engagement of clinical engineers, procurement professionals, refurbishing specialists, and imaging clinicians. Secondary sources provided context on technological trends, detector performance characteristics, and regulatory frameworks, while primary interviews offered operational perspectives on procurement cycles, installation challenges, and service expectations.

Data triangulation ensured consistency across qualitative inputs and technical documentation, and thematic coding was applied to interview transcripts to surface recurring priorities such as uptime, documentation rigor, and parts availability. Case studies of facility-level deployments informed practical considerations for installation, training, and acceptance testing. In addition, supplier capability assessments focused on validation protocols, warranty structure, spare-parts logistics, and remote diagnostic capabilities.

Throughout, the methodology emphasized reproducibility and transparency by documenting inclusion criteria for sources, interview protocols, and the analytical framework used to align segmentation dimensions with regional and competitive factors. This approach supports credible, actionable findings that reflect both technical realities and operational constraints relevant to refurbished C-arm procurement and deployment.

A conclusive synthesis that positions refurbished C-arms as strategic, sustainable imaging assets when governance, standards, and supply resilience are aligned

Refurbished C-arms represent a pragmatic intersection of clinical capability and capital stewardship that can meaningfully expand access to interventional and diagnostic imaging across diverse care settings. The convergence of improved refurbishment standards, greater clinical acceptance, and adaptive procurement models positions refurbished systems as durable components of modern imaging strategies. Nevertheless, realizing this potential requires disciplined validation protocols, resilient supply chains, and tight collaboration between clinical and engineering stakeholders to ensure consistent performance and regulatory compliance.

Decision-makers should therefore treat refurbishment as a strategic element of asset management, integrating it into lifecycle planning, maintenance budgeting, and procedural deployment roadmaps. By doing so, organizations can preserve clinical throughput, support expanding outpatient procedural volumes, and respond agilely to shifting demand patterns. In summary, refurbished C-arms provide an actionable pathway to balance fiscal responsibility with clinical excellence when stakeholders adopt rigorous standards, diversify sourcing, and prioritize service continuity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Refurbished C-Arms Market, by Product Type

  • 8.1. Fixed
  • 8.2. Mobile

9. Refurbished C-Arms Market, by Detector Type

  • 9.1. Flat Panel Detector
  • 9.2. Image Intensifier

10. Refurbished C-Arms Market, by Technology

  • 10.1. Analog
  • 10.2. Digital

11. Refurbished C-Arms Market, by Application

  • 11.1. Cardiology
    • 11.1.1. Diagnostic Cardiology
    • 11.1.2. Interventional Cardiology
  • 11.2. Gastroenterology
  • 11.3. General Surgery
    • 11.3.1. Minimally Invasive Surgery
    • 11.3.2. Open Surgery
  • 11.4. Neurology
  • 11.5. Orthopedics
  • 11.6. Pain Management
  • 11.7. Urology

12. Refurbished C-Arms Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Diagnostic Centers
  • 12.4. Hospitals
    • 12.4.1. Government Hospitals
    • 12.4.2. Private Hospitals

13. Refurbished C-Arms Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Refurbished C-Arms Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Refurbished C-Arms Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Refurbished C-Arms Market

17. China Refurbished C-Arms Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agito Medical A/S
  • 18.6. Avante Health Solutions, Inc.
  • 18.7. Block Imaging, Inc.
  • 18.8. Canon Medical Systems Corporation
  • 18.9. Carestream Health, Inc.
  • 18.10. EverX Pty Ltd
  • 18.11. Fair Medical Co., Ltd.
  • 18.12. Fujifilm Healthcare
  • 18.13. Future Health Concepts, Inc.
  • 18.14. GE Healthcare, Inc.
  • 18.15. Hilditch Group Ltd.
  • 18.16. Hitachi Medical Systems
  • 18.17. Integrity Medical Systems, Inc.
  • 18.18. Koninklijke Philips N.V.
  • 18.19. Master Medical Equipment, LLC
  • 18.20. Nationwide Imaging Services, Inc.
  • 18.21. Pacific Healthcare Imaging, LLC
  • 18.22. Radiology Oncology Systems, Inc. (ROS)
  • 18.23. Radon Medical Imaging LLC
  • 18.24. Siemens Healthineers AG
  • 18.25. Soma Technology, Inc.
  • 18.26. Ultra Imaging Solutions, LLC
  • 18.27. US Med-Equip, Inc.
  • 18.28. Venture Medical ReQuip, Inc.
  • 18.29. Whittemore Enterprises, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL REFURBISHED C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL REFURBISHED C-ARMS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL REFURBISHED C-ARMS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES REFURBISHED C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA REFURBISHED C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL REFURBISHED C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY FIXED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY FIXED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY FIXED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY MOBILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY MOBILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY MOBILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY FLAT PANEL DETECTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY FLAT PANEL DETECTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY FLAT PANEL DETECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY ANALOG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY ANALOG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY ANALOG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY DIGITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY DIGITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY DIGITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY DIAGNOSTIC CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY DIAGNOSTIC CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY DIAGNOSTIC CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS REFURBISHED C-ARMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA REFURBISHED C-ARMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 162. GCC REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GCC REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. GCC REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. GCC REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. GCC REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. GCC REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. GCC REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 169. GCC REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. GCC REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 189. G7 REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. G7 REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. G7 REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. G7 REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. G7 REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. G7 REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. G7 REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 196. G7 REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. G7 REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 198. NATO REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. NATO REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. NATO REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. NATO REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. NATO REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. NATO REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 204. NATO REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 205. NATO REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. NATO REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES REFURBISHED C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA REFURBISHED C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)